MADRIGAL PHARMA Stock Price (NASDAQ:MDGL)

Add to My Stocks
$135.95 $0.84 (0.62%) MDGL stock closing price Feb 20, 2018 (Closing)
Prev Close* : $135.11
Market Cap:
$1.89B
Day Low: $133
52 Week Low: $13.09
Open: $134.12
Volume: -
Day High: $137.98
52 Week High: $154.75
Dividend:
0.00

Latest Stock Market News

Latest Articles

MADRIGAL PHARMA News - From Partners

5 Top Multibagger Stocks to Buy in 2018   by Zacks on Jan 02, 2018

MDGL Stockcharts

View MDGL PE ratio, PS ratio stocks charts and compare with peers.
MDGL Chart
Note: Compare MADRIGAL PHARMA stock price history with the index and industry peers.

MADRIGAL PHARMA Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

MADRIGAL PHARMA Returns

ROE
(return on equity)
-68%

MADRIGAL PHARMA Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

MDGL Industry Peers

Company Price Change (%)
Aerie Pharma (AERI)54.20.7 (1.28%)
Auxilium Pharma (AUXL)36.470.06 (0.16%)
Esperion Therapeutics (ESPR)75.790.87 (1.16%)
Ignyta (RXDX)26.950 (0%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)323.049.11 (2.74%)
Alexion Pharma (ALXN)118.851.62 (1.34%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Endocyte (ECYT)3.570.39 (12.26%)
ACER THERAPEUTS (ACER)18.120.75 (4.32%)
Tesaro Inc (TSRO)62.32.3 (3.83%)
Pacira Pharma (PCRX)31.251.1 (3.65%)
MediWound (MDWD)4.50.15 (3.45%)
Regulus Therapeutics (RGLS)1.230.03 (2.5%)
BioCryst Pharma (BCRX)5.060.1 (2.02%)
Top gainers from Medical-Drugs industry
* As of Feb 20, 2018
CompanyPriceChange (%)
Catalyst Pharma (CPRX)3.240.19 (5.54%)
Shire (SHPG)126.677.39 (5.51%)
Heron Therapeutics (HRTX)22.51.3 (5.46%)
Synergy Pharma (SGYP)1.920.11 (5.42%)
TherapeuticsMD (TXMD)5.310.27 (4.84%)
Enanta Pharma (ENTA)77.963.62 (4.44%)
Lannett Co (LCI)16.30.75 (4.4%)
Top losers from Medical-Drugs industry
* As of Feb 20, 2018

MADRIGAL PHARMA Stock News - Partner Headlines

MADRIGAL PHARMA Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-26.38M-68.67M-86.16M-90.19M-62.79M
Total Operating Expense25.22M67.6M83.94M87.55M61.08M
View MADRIGAL PHARMA income statement
balance sheet20162015201420132012
Total Assets41.21M68.19M100.67M95.2M103.01M
Total Liabilities4.79M17.78M35.53M46.11M27.95M
Shareholders Equity36.41M50.4M65.13M49.09M75.06M
View MADRIGAL PHARMA balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.1M-7.73M-0.86M6.23M4.59M
Net Cash from (used by) Operating Activities-17.6M-71.44M-78.92M-77.41M-54.13M
Increase (Decrease) in Prop Plant And Equipment--0.05M-0.14M-0.76M-0.5M
View MADRIGAL PHARMA cash flow statement

MADRIGAL PHARMA Stock Message Board

MADRIGAL PHARMA stock price ended the last trading day at $135.95. Stock price or share price can be used to find the total market value of a company. MADRIGAL PHARMA market cap stands at $1.89B as of Feb 20, 2018. A value investor must look at the fundamentals of a stock, and perform MADRIGAL PHARMA valuation, even though in the short-term, sentiment and current breaking news might affect MADRIGAL PHARMA stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that MADRIGAL PHARMA is worth a lot, it will most likely be reflected in an inflated MADRIGAL PHARMA stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 112,022 shares were traded with a closing stock price of $135.95 as of Feb 20, 2018, as can be seen from MADRIGAL PHARMA stock quote. One can view MADRIGAL PHARMA stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. MADRIGAL PHARMA does not pay dividends. To check the historical stock price movement, all time high, and all time low of MDGL, view MADRIGAL PHARMA stock price history.